跳至主要内容
临床试验/NL-OMON54765
NL-OMON54765已完成4 期

A prospective, observational, multi-centre study investigating alterations of gut microbiome with its subsequent interaction on the brain-immune-intestine axis in patients with active relapsing remitting Multiple Sclerosis who start with oral treatment. - BIA study

Sint Elisabeth Ziekenhuis0 个研究点目标入组 72 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 64(—)

入选标准

  • 1. The subject must give written informed consent
  • 2. Males and females in the age of >= 18 and <= 60 years
  • 3. Planned start Cladribine treatment within 4 weeks from screening
  • 4. The subject must be prepared to and considered able to follow the protocol
  • during the whole trial period

排除标准

  • 1. Has used probiotics within one month prior to start Cladribine

研究者

发起方
Sint Elisabeth Ziekenhuis

相似试验

A prospective, observational, multi-centre study... | 临床试验